ClassID:

94576

C07D249/06 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Recent Application in this class:
#1
20260138966
2026-05-21

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#2
20260124201
2026-05-07

CYCLOPENTANE COMPOUND

#3
20260098019
2026-04-09

SYNTHESIS OF NSAID CONJUGATES AS ANTI-INFLAMMATORY AGENTS USING THE MOLECULAR HYBRIDIZATION

#4
20260049078
2026-02-19

DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS

#5
20260035360
2026-02-05

INHIBITORS OF MYC AND USES THEREOF

#6
20260034094
2026-02-05

COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS

#7
20260001871
2026-01-01

TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D

#8
20250313538
2025-10-09

Histone Deacetylase (HDAC) Inhibitors Targeting Prostate Tumors

#9
20250304539
2025-10-02

TYPE OF NOVEL LIPID COMPOUND AND USE THEREOF

#10
20250282736
2025-09-11

SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR

#11
20250243172
2025-07-31

NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF

#12
20250228865
2025-07-17

COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME

#13
20250214930
2025-07-03

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

#14
20250197355
2025-06-19

TEAD Targeting Compounds and Methods Thereof

#15
20250188068
2025-06-12

AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS

#16
20250129012
2025-04-24

ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS AND USE THEREOF

#17
20250099433
2025-03-27

COMPOSITION AND METHOD FOR TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTION

#18
20250084040
2025-03-13

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#19
20250075265
2025-03-06

ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS

#20
20250064787
2025-02-27

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

#21
20250057815
2025-02-20

CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

#22
20250002476
2025-01-02

AZOLE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS

#23
20240425547
2024-12-26

PSMA Imaging Agents

#24
20240409580
2024-12-12

PSMA Imaging Agents

#25
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

#26
20240343695
2024-10-17

Lysophosphatidic Acid Receptor 1 Antagonists as Migrastatics for Cancer

#27
20240327334
2024-10-03

Covalent Inhibitors As Antiviral Agents

#28
20240317709
2024-09-26

Lysophosphatidic Acid Receptor Antagonists for Breast Cancer Treatment

#29
20240300968
2024-09-12

6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES

#30
20240279191
2024-08-22

SMALL MOLECULE INHIBITORS OF TEAD-YAP

#31
20240262812
2024-08-08

N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF

#32
20240254079
2024-08-01

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

#33
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#34
20240208981
2024-06-27

NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#35
20240208927
2024-06-27

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#36
20240199575
2024-06-20

COMPOUNDS USEFUL FOR TREATING LIVER DISEASES

#37
20240174619
2024-05-30

VALIOLAMINE DERIVATIVES AS GLUCOSIDASE INHIBITORS

#38
20240166611
2024-05-23

Triazole derivative and use thereof

#39
20240150290
2024-05-09

HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS

#40
20240124371
2024-04-18

NITRIFICATION INHIBITORS AND FORMULATIONS

#41
20240092742
2024-03-21

REAGENT FOR MASS SPECTROMETRY

#42
20240092741
2024-03-21

COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROFIBROMATOSIS TYPE 2 SYNDROME

#43
20240092725
2024-03-21

ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#44
20240091200
2024-03-21

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

#45
20240025858
2024-01-25

CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHOD OF PREPARATION THEREOF

#46
20230406878
2023-12-21

OLIGONUCLEOTIDES, REAGENTS, AND PREPARATION THEREOF

#47
20230390249
2023-12-07

CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

#48
20230373985
2023-11-23

KINASE MODULATORS AND METHODS OF USE THEREOF

#49
20230348404
2023-11-02

BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF

#50
20230348369
2023-11-02

NAMPT MODULATORS

#51
20230339884
2023-10-26

Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists

#52
20230286948
2023-09-14

HALOALKYLPYRIDYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR

#53
20230286925
2023-09-14

PHENYL TRIAZOLE MLL1-WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR

#54
20230286904
2023-09-14

INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF

#55
20230257343
2023-08-17

NOVEL AMINO ACID DERIVATIVES

#56
20230250093
2023-08-10

AMIDO CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS

#57
20230250086
2023-08-10

METHIONINE METABOLIC PATHWAY INHIBITORS

#58
20230232828
2023-07-27

SULPHONAMIDES AS METHIONINE METABOLIC PATHWAY INHIBITORS

#59
20230174523
2023-06-08

BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF

#60
20230113202
2023-04-13

GPR84 ANTAGONISTS AND USES THEREOF

#61
20230104647
2023-04-06

METHODS AND PROCESSES FOR THE PREPARATION OF KDM1A INHIBITORS

#62
20230098016
2023-03-30

Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction

#63
20230024283
2023-01-26

HERBICIDAL COMPOUNDS

#64
20230021476
2023-01-26

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

#65
20220396551
2022-12-15

EBNA1 inhibitors and their method of use

#66
20220324829
2022-10-13

Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

#67
20220324814
2022-10-13

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

#68
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#69
20220298138
2022-09-22

ENZYME INHIBITORS

#70
20220289754
2022-09-15

IMPROVED SYNTHETIC METHODS OF MAKING (2H-1, 2, 3-TRIAZOL-2-YL) PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS

#71
20220289690
2022-09-15

SECOND GENERATION INHIBITORS OF MITOCHONDRIAL PERMEABILITY TRANSITION PORE WITH IMPROVED PLASMA STABILITY

#72
20220281860
2022-09-08

COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES

#73
20220249443
2022-08-11

CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

#74
20220194904
2022-06-23

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

#75
20220185785
2022-06-16

INHIBITORS OF CD40-CD154 BINDING

#76
20220144733
2022-05-12

HEXASUBSTITUTED BENZENES, SURFACES MODIFIED THEREWITH, AND ASSOCIATED METHODS

#77
20220131190
2022-04-28

Electrolyte solution for lithium secondary battery and lithium secondary battery comprising same

#78
20220112159
2022-04-14

Sulfonylureas and related compounds and use of same

#79
20220111060
2022-04-14

Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer

#80
20220081401
2022-03-17

SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF

#81
20220081381
2022-03-17

VDR-silent vitamin D derivative as inhibitors of SREBP and pharmaceutical use thereof

#82
20220073477
2022-03-10

KDM1A inhibitors for the treatment of disease

#83
20220073476
2022-03-10

TRIAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF

#84
20220041565
2022-02-10

Cyclopentyl acids as LPA antagonists

#85
20220024876
2022-01-27

Small molecule inhibition of sulfotransferase SULT1A3

#86
20220017472
2022-01-20

Arylazole compound and pest control agent

#87
20210403440
2021-12-30

Substituted tolyl fungicides

#88
20210395206
2021-12-23

Substituted heterocycles as c-MYC targeting agents

#89
20210363107
2021-11-25

Microbiocidal compounds

#90
20210347715
2021-11-11

Hexasubstituted benzenes, surfaces modified therewith, and associated methods

#91
20210317079
2021-10-14

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

#92
20210309650
2021-10-07

Process for the preparation of an orexin receptor antagonist

#93
20210300890
2021-09-30

Compounds Useful for Treating Liver Diseases

#94
20210244711
2021-08-12

CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

#95
20210238192
2021-08-05

VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF

#96
20210221781
2021-07-22

Fatty acid analogues and methods of use

#97
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

#98
20210198217
2021-07-01

Reagent for mass spectrometry

#99
20210189214
2021-06-24

Antifreezing coolant composition not including glycol

#100
20210188788
2021-06-24

REAGENT FOR MASS SPECTROMETRY

#101
20210188785
2021-06-24

Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives

#102
20210188763
2021-06-24

COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION

#103
20210179535
2021-06-17

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

#104
20210171475
2021-06-10

Compounds which are inhibitors of Notum

#105
20210163425
2021-06-03

TRIAZOLE DERIVATIVE AND USE THEREOF

#106
20210139466
2021-05-13

Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction

#107
20210139437
2021-05-13

Methods and processes for the preparation of KDM1A inhibitors

#108
20210128532
2021-05-06

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

#109
20210114997
2021-04-22

Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

#110
20210062251
2021-03-04

Enhancement of nucleic acid polymerization by aromatic compounds

#111
20210060205
2021-03-04

AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF

#112
20210053924
2021-02-25

Heterocyclic compounds as pesticides

#113
20210047293
2021-02-18

Heterocyclic P2Yreceptor antagonists

#114
20210032286
2021-02-04

PSMA Imaging Agents

#115
20210024574
2021-01-28

PSMA imaging agents

#116
20210017136
2021-01-21

Heterocyclic compounds as pesticides

#117
20200397000
2020-12-24

Unusually potent ABA receptor pan-antagonists

#118
20200377549
2020-12-03

PSMA imaging agents

#119
20200377457
2020-12-03

MIF MODULATORS

#120
20200354325
2020-11-12

Benzosulfonyl compounds

#121
20200345700
2020-11-05

LSD1 inhibitor and preparation method and application thereof

#122
20200331872
2020-10-22

Methionine metabolic pathway inhibitors

#123
20200329705
2020-10-22

Sulphonamides as methionine metabolic pathway inhibitors

#124
20200299270
2020-09-24

Proteostasis regulators

#125
20200299261
2020-09-24

WNT signaling pathway inhibitors for treatments of disease

#126
20200283397
2020-09-10

KDM1A inhibitors for the treatment of disease

#127
20200231555
2020-07-23

Tetrazole compounds and their use in the treatment of tuberculosis

#128
20200181078
2020-06-11

EBNA1 inhibitors and their method of use

#129
20200148665
2020-05-14

Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists

#130
20200140398
2020-05-07

Human helicase DDX3 inhibitors as therapeutic agents

#131
20200138789
2020-05-07

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

#132
20200123114
2020-04-23

Calpain modulators and therapeutic uses thereof

#133
20200115372
2020-04-16

COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES

#134
20200071281
2020-03-05

1,4,5-substituted 1,2,3-triazole analogues as antagonists of the pregnane X receptor

#135
20190375720
2019-12-12

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

#136
20190367460
2019-12-05

Heterocyclic compounds as pesticides

#137
20190367459
2019-12-05

Heterocyclic compounds as pesticides

#138
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

#139
20190337910
2019-11-07

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#140
20190322630
2019-10-24

1,2,3-triazole derivative and insecticide and acaricide containing said derivative as active ingredient

#141
20190322629
2019-10-24

Methods of preparing regioselective N-alkyl triazoles

#142
20190276415
2019-09-12

Piperazine derivatives having multimodal activity against pain

#143
20190270706
2019-09-05

MIF modulators

#144
20190218194
2019-07-18

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#145
20190209696
2019-07-11

Synthetic antibody mimetic compounds (SyAMs) targeting cancer, especially prostate cancer

#146
20190185446
2019-06-20

Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists

#147
20190161490
2019-05-30

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#148
20190121233
2019-04-25

Chemically amplified positive-type photosensitive resin composition, photosensitive dry film, method of manufacturing photosensitive dry film, method of manufacturing patterned resist film, method of manufacturing substrate with template, method of manufacturing plated article, and mercapto compound

#149
20190119223
2019-04-25

Modulators of indoleamine 2,3-dioxygenase

#150
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#151
20190111028
2019-04-18

Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses Thereof

#152
20190083467
2019-03-21

Aromatic ring compound

#153
20190077770
2019-03-14

1,4,5-substituted 1,2,3-triazole analogues as antagonists of the pregnane X receptor

#154
20190071424
2019-03-07

Wnt signaling pathway inhibitors for treatments of disease

#155
20190062281
2019-02-28

Substituted heterocycles as c-MYC targeting agents

#156
20190062261
2019-02-28

Alpha-truxillic acid derivatives and pharmaceutical compositions thereof

#157
20190040018
2019-02-07

Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds

#158
20190022068
2019-01-24

TRPM8 receptor agonist compounds and uses thereof

#159
20190022037
2019-01-24

Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies

#160
20190015387
2019-01-17

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#161
20180370953
2018-12-27

Bis-triazole compounds with anti-biofilm and anti-corrosion properties

#162
20180362470
2018-12-20

Arylazole compound and pest control agent

#163
20180333395
2018-11-22

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

#164
20180327363
2018-11-15

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis

#165
20180312474
2018-11-01

KDM1A inhibitors for the treatment of disease

#166
20180297963
2018-10-18

Broad spectrum antiviral compounds and uses thereof

#167
20180291207
2018-10-11

Chromophores for photochromic compositions useful for three dimensional display applications

#168
20180290986
2018-10-11

1,2,3-triazole derivative and insecticide and acaricide containing said derivative as active ingredient

#169
20180289007
2018-10-11

Compounds for controlling arthropods

#170
20180258134
2018-09-13

PSMA imaging agents

#171
20180244653
2018-08-30

Selective alpha-7 nicotinic receptor agonists and methods for making and using them

#172
20180235939
2018-08-23

Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses Thereof

#173
20180228924
2018-08-16

Methylsulfonamide derivatives and uses related thereto

#174
20180222866
2018-08-09

Trypanosomes inhibitors

#175
20180222857
2018-08-09

Aryl sulfonohydrazides

#176
20180186756
2018-07-05

Disubstituted triazole analogs

#177
20180162813
2018-06-14

MIF modulators

#178
20180160686
2018-06-14

Diarylazole compound and harmful organism control agent

#179
20180127353
2018-05-10

Compounds for use as therapeutic agents affecting P53 expression and/or activity

#180
20180105509
2018-04-19

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

#181
20180105485
2018-04-19

Cyclic vinylogous amides as bromodomain inhibitors

#182
20180086699
2018-03-29

EBNA1 inhibitors and their method of use

#183
20180072745
2018-03-15

IRE-1alpha INHIBITORS

#184
20180050995
2018-02-22

Process for the preparation of triazoles

#185
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same

#186
20180030003
2018-02-01

Tricyclic compounds and uses thereof in medicine

#187
20180016243
2018-01-18

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

#188
20180002298
2018-01-04

COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#189
20170369783
2017-12-28

Polymerizable compound and optically anisotropic object

#190
20170369454
2017-12-28

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

#191
20170360759
2017-12-21

Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists

#192
20170313652
2017-11-02

Poly-cyanostilbene macrocycles

#193
20170305943
2017-10-26

COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#194
20170305864
2017-10-26

Heterocyclic compounds as pesticides

#195
20170304239
2017-10-26

Inhibitors of human immunodeficiency virus replication

#196
20170253581
2017-09-07

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#197
20170253568
2017-09-07

Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds

#198
20170247355
2017-08-31

Proteostasis regulators

#199
20170224830
2017-08-10

PAK1-blocking 1,2,3-triazolyl esters

#200
20170217947
2017-08-03

Route of synthesis for the preparation of suvorexant

#201
20170217910
2017-08-03

INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES

#202
20170210700
2017-07-27

3-aryl propiolonitrile compounds for thiol labeling

#203
20170197924
2017-07-13

1,2,3 Triazole antifungal agents and preparation thereof

#204
20170166576
2017-06-15

IRE-1alpha inhibitors

#205
20170137389
2017-05-18

Linker molecule for multiplex recognition by atomic force microscopy (AFM)

#206
20170112843
2017-04-27

Compounds and methods for inducing chondrogenesis

#207
20170088529
2017-03-30

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#208
20170081295
2017-03-23

Propellane derivates and synthesis

#209
20170073322
2017-03-16

Surfactant-Enabled Transition Metal-Catalyzed Chemistry

#210
20170044373
2017-02-16

Chromophores for photochromic compositions useful for three dimensional display applications

#211
20170044195
2017-02-16

Ruthenium-based triazole carbene complexes

#212
20170044148
2017-02-16

GPR40 agonists for the treatment of type II diabetes

#213
20170044147
2017-02-16

GPR40 agonists for the treatment of type II diabetes

#214
20170044146
2017-02-16

GPR40 agonists for the treatment of type II diabetes

#215
20170027173
2017-02-02

INSECTICIDAL COMPOUNDS

#216
20170015635
2017-01-19

Disubstituted triazole analogs

#217
20170001967
2017-01-05

Piperazine derivatives having multimodal activity against pain

#218
20160347708
2016-12-01

Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides

#219
20160347677
2016-12-01

Surfactant-enabled transition metal-catalyzed chemistry

#220
20160340332
2016-11-24

Compositions comprising TPGS-750-M

#221
20160326120
2016-11-10

N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives

#222
20160326104
2016-11-10

Cyclohexyl sulfone RORγ modulators

#223
20160318852
2016-11-03

Benzamides and nicotinamides as Syk modulators

#224
20160304555
2016-10-20

PSMA imaging agents

#225
20160302414
2016-10-20

INSECTICIDAL COMPOUNDS

#226
20160297777
2016-10-13

Small molecule inhibitors of PI3-kinase signaling

#227
20160289185
2016-10-06

EBNA1 inhibitors and their method of use

#228
20160280669
2016-09-29

Compounds and methods

#229
20160280668
2016-09-29

Compounds for combating arthropods

#230
20160272577
2016-09-22

ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

#231
20160264566
2016-09-15

Anti-alphavbeta1 integrin inhibitors and methods of use

#232
20160250193
2016-09-01

Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof

#233
20160237043
2016-08-18

KDM1A inhibitors for the treatment of disease

#234
20160229816
2016-08-11

Cyanotriazole compounds

#235
20160200673
2016-07-14

Antibacterial compounds

#236
20160200666
2016-07-14

Cyclic vinylogous amides as bromodomain inhibitors

#237
20160176824
2016-06-23

1,3-Disubstituted cyclopentane derivatives

#238
20160152621
2016-06-02

Aryl lactam kinase inhibitors

#239
20160145199
2016-05-26

3-aryl propiolonitrile compounds for thiol labeling

#240
20160090375
2016-03-31

Substituted phenylazole derivative

#241
20160082112
2016-03-24

Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer

#242
20160031839
2016-02-04

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#243
20150353510
2015-12-10

1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders

#244
20150352079
2015-12-10

Selective histone deacetylase 8 inhibitors

#245
20150344450
2015-12-03

Synthesis, structure and use of functionalized naphthalenes

#246
20150335023
2015-11-26

Substituted benzene fungicides

#247
20150315126
2015-11-05

Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A

#248
20150299123
2015-10-22

S1P and/or ATX modulating agents

#249
20150291551
2015-10-15

Ingenol-3-acylates III and ingenol-3-carbamates

#250
20150289505
2015-10-15

Herbicide composition

#251
20150284343
2015-10-08

Substituted triazoles as herbicides

#252
20150266859
2015-09-24

Glucagon receptor modulators

#253
20150266850
2015-09-24

SUBSTITUTED TOLYL FUNGICIDES

#254
20150259305
2015-09-17

CATALYTIC REACTION

#255
20150239847
2015-08-27

Heterocyclic compounds as pesticides

#256
20150225388
2015-08-13

Compounds for use in the treatment of mycobacterial infections

#257
20150158831
2015-06-11

Substituted indenes as medicaments

#258
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#259
20150133512
2015-05-14

N-ARYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS

#260
20150133511
2015-05-14

N-alkyltriazole compounds as LPAR antagonists

#261
20150133468
2015-05-14

Methanethione compounds having antiviral activity

#262
20150105410
2015-04-16

POLYMORPHIC FORMS OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND USES THEREOF

#263
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

#264
20150094337
2015-04-02

Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof

#265
20150094294
2015-04-02

COMPOUNDS AND METHODS FOR TREATING MALARIA

#266
20150073026
2015-03-12

1, 2, 4-triazole derivatives and their anti-microbial activity

#267
20150065521
2015-03-05

TRIAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 MODULATORS

#268
20150051256
2015-02-19

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

#269
20150038492
2015-02-05

Benzamides and nicotinamides as Syk modulators

#270
20150031738
2015-01-29

Cyclic compounds and methods of making and using the same

#271
20150018371
2015-01-15

Positive allosteric modulators for melanocortin receptors

#272
20150018337
2015-01-15

N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides

#273
20150011773
2015-01-08

Radiolabeled amino acids for diagnostic imaging

#274
20150011604
2015-01-08

Compounds for the treatment of neurodegenerative diseases

#275
20140371467
2014-12-18

Glucagon receptor modulators

#276
20140371465
2014-12-18

1,2,3-triazole based metal-organic framework as photo-active materials

#277
20140357675
2014-12-04

Substituted phenylazole derivatives

#278
20140329812
2014-11-06

Aryl triazole compounds with antitumoural activity

#279
20140315961
2014-10-23

Arginine methyltransferase inhibitors and uses thereof

#280
20140309264
2014-10-16

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#281
20140303150
2014-10-09

Ingenol-3-acylates III and ingenol-3-carbamates

#282
20140302386
2014-10-09

Compounds having a redox group, use thereof as an electrolyte additive, electrolyte composition, and electrochemical systems containing same

#283
20140228219
2014-08-14

Cyclohexanone compounds and herbicides comprising the same

#284
20140206690
2014-07-24

Compounds for use as therapeutic agents affecting p53 expression and/or activity

#285
20140200247
2014-07-17

Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations

#286
20140194620
2014-07-10

18F-labeled precursor of PET radioactive medical supplies, and preparation method thereof

#287
20140179626
2014-06-26

Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same

#288
20140155436
2014-06-05

Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies

#289
20140142304
2014-05-22

Process for producing an aminopropyne or enaminone

#290
20140113012
2014-04-24

Compounds and methods for inducing chondrogenesis

#291
20140107168
2014-04-17

G-quadruplex stabilising agent

#292
20140073633
2014-03-13

Inhibitors of the shiga toxins trafficking through the retrograde pathway

#293
20140066632
2014-03-06

Copper-catalysed ligation of azides and acetylenes

#294
20140038975
2014-02-06

Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents

#295
20140018318
2014-01-16

N1- and N2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods

#296
20140005132
2014-01-02

Contraceptive agents

#297
20130338202
2013-12-19

Compounds for the treatment of neurodegenerative diseases

#298
20130338112
2013-12-19

Compounds for the treatment of proliferative disorders

#299
20130331379
2013-12-12

Process for the preparation of an orexin receptor antagonist

#300
20130315841
2013-11-28

Functionalized naphthalene fluorophores